Forward Pharma A/S Cash and Cash Equivalents 2011-2026 | FWP

Annual Cash and Cash Equivalents Forward Pharma A/S

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
70.8 M	79.1 M	77.6 M	82.5 M	110 M	57.9 M	52.3 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
110 M	52.3 M	75.7 M

Quarterly Cash and Cash Equivalents Forward Pharma A/S

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	70.8 M	-	75.1 M	-	79.1 M	-	75.6 M	-	77.6 M	-	-	-	82.5 M	-	89.3 M	-	110 M	-	1.36 B	-	57.9 M	-	-	-	52.3 M	-	-	-	45.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.36 B	45.3 M	181 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
AbCellera Biologics ABCL	129 M	$ 3.53	-0.98 %	$ 1.05 B	Canada
Acorda Therapeutics ACOR	30 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	22.1 M	-	4.01 %	$ 150 M	Canada
Advaxis ADXS	4.88 M	-	-9.65 %	$ 45.9 M	USA
AC Immune SA ACIU	36.3 M	$ 3.21	2.56 %	$ 229 M	Schweiz
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
AgeX Therapeutics AGE	345 K	-	-10.17 %	$ 12.2 K	USA
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Albireo Pharma ALBO	248 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	12.9 M	-	10.36 %	$ 9.8 M	USA
Aptorum Group Limited APM	3.5 M	$ 0.79	0.01 %	$ 4.31 M	China
ADC Therapeutics SA ADCT	326 M	$ 4.12	-1.9 %	$ 105 M	Schweiz
Arcturus Therapeutics Holdings ARCT	231 M	$ 6.59	-0.6 %	$ 180 M	Israel
argenx SE ARGX	1.5 B	$ 709.76	0.92 %	$ 25 B	Niderland
Midatech Pharma plc MTP	1.67 M	-	-18.52 %	$ 27.3 M	Britain
Adverum Biotechnologies ADVM	60.7 M	-	-	$ 86.2 M	USA
Alterity Therapeutics Limited ATHE	34.8 M	$ 3.41	-5.54 %	$ 8.2 B	Australia
Ascendis Pharma A/S ASND	616 M	$ 229.9	-0.49 %	$ 5 B	Danmark
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
Applied Molecular Transport AMTI	61.1 M	-	-	$ 10.1 M	USA
Atea Pharmaceuticals AVIR	95.7 M	$ 6.08	0.5 %	$ 495 M	USA
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
BioCardia BCDA	1.1 M	$ 1.28	0.55 %	$ 27.1 M	USA
Athersys ATHX	37.4 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
Acer Therapeutics ACER	2.33 M	-	2.71 %	$ 14 M	USA
ARCA biopharma ABIO	61.6 M	-	1052.0 %	$ 415 M	USA
Allena Pharmaceuticals ALNA	30 M	-	3.16 %	$ 1.9 M	USA
Aeterna Zentaris AEZS	16.4 M	-	5.93 %	$ 314 M	Canada
AlloVir ALVR	118 M	-	4.14 %	$ 49.1 M	USA
Anika Therapeutics ANIK	72.9 M	$ 14.49	0.91 %	$ 212 M	USA
Aptinyx APTX	56.2 M	-	-39.0 %	$ 4.57 M	USA
Aptose Biosciences APTO	6.15 M	-	-45.71 %	$ 1.2 M	Canada
AVEO Pharmaceuticals AVEO	70.5 M	-	-	$ 521 M	USA
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	31 M	$ 2.64	-	$ 16.6 M	USA
Avenue Therapeutics ATXI	2.59 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	240 M	$ 1.51	-	$ 385 M	Britain
Athira Pharma ATHA	48.4 M	-	-	$ 269 M	USA
BioNTech SE BNTX	7.68 B	$ 92.27	1.91 %	$ 27.2 B	Germany
CureVac N.V. CVAC	811 M	-	-	$ 867 M	Germany
Aravive ARAV	53.7 M	-	-13.39 %	$ 1.45 M	USA
Burford Capital Limited BUR	322 M	$ 8.27	2.61 %	$ 1.34 B	Britain
AstraZeneca PLC AZN	5.71 B	-	-	$ 96.9 B	Britain
Actinium Pharmaceuticals ATNM	72.9 M	$ 1.16	4.5 %	$ 34.9 M	USA